Skip to main content

Table 2 Clinical characteristics of pediatric COVID-19

From: Epidemiological and clinical features of pediatric COVID-19

Classification Characteristic (No., %)
Clinical diagnosis 341
 Asymptomatic 20 (5.9%)
  With abnormal chest radiograph 6 (30%)
 Mild/moderate 318 (99.3%)
 Severe 2 (0.6%)
 Critical 1 (0.3%)
Clinical symptoms 136
 Fever (37.3~40 °C) 106 (77.9%)
 Cough 44 (32.4%)
 Lacrimation 6 (4.4%)
 Stuffy nose 3 (2.2%)
 Sneezing 1 (0.7%)
 Sore throat 3 (2.2%)
 Dyspnea 3 (2.2%)
 Nausea & vomiting 4 (2.9%)
 Diarrhea 6 (4.4%)
 Conjunctivitis 1 (0.7%)
 Dizziness and headache and myalgia 3 (2.2%)
 Fatigue 3 (2.2%)
 Body discomfort 3 (2.2%)
Coexisting disorders 136
 Congenital heart 2 (1.5%)
Complications 136
 Heart failure 1 (0.7%)
 Myocardial injury 6 (4.4%)
 Liver injury 3 (2.2%)
 Acute respiratory distress syndrome/shock/acute kidney injury 1 (0.7%)
Treatment 62
 Antiviral treatment 33 (53.2%)
 TCM 27 (43.5%)
 Antibiotic treatment 17 (27.4%)
 Nutritional support therapy 17 (27.4%)
 Symptomatic treatment 17 (27.4%)
 Interferon therapy 7 (11.3%)
 Immunoglobulin therapy 4 (6.5%)
 Psychological intervention 2 (3.2%)
 Not taking medicine 1 (1.6%)
 Glucocorticoid therapy 1 (1.6%)
 Mechanical ventilation 1 (1.6%)
Clinical outcome
 Death 0/341
Time from onset to cure (days) 218
 Median (range) 16 (6–39)
 Quartile (Q1–Q3) 13–21